Exchange Announcement • 17 Jul 2024 15:17
Exchange Announcement • 15 Jul 2024 18:58
Exchange Announcement • 15 Jul 2024 17:29
Exchange Announcement • 12 Jul 2024 18:53
Exchange Announcement • 12 Jul 2024 18:03
ENTITY
Lupin Ltd (LPC IN)
Lupin Ltd (LPC IN)
165
Analysis
Health Care • India
Lupin Limited manufactures bulk actives and formulations. The principal bulk actives manufactured by it include Rifampicin, Pyrazinamide, Ethambutol (anti-TB), Cephalosporins (anti-infectives) and cardiovasculars. The company also possesses competencies in phytomedicines, in which medicines are made out of plant and herbal resources supported by the discipline of modern medicine.
more
x